1,2-dimethylhydrazine multiple interactions EXP 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of LAMA5 mRNA CTD PMID:27840820 1,2-dimethylhydrazine increases expression ISO RGD:1551147 6480464 1, 2-Dimethylhydrazine results in increased expression of LAMA5 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:1551147 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of LAMA5 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of LAMA5 mRNA CTD PMID:30723492 17alpha-ethynylestradiol multiple interactions ISO RGD:1551147 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LAMA5 mRNA CTD PMID:17942748 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1551147 6480464 Dihydrotestosterone results in increased expression of LAMA5 mRNA CTD PMID:17023530 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1551147 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1551147 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LAMA5 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1551147 6480464 Tetrachlorodibenzodioxin results in decreased expression of LAMA5 mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LAMA5 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LAMA5 mRNA CTD PMID:22298810 , PMID:34747641 2,4,6-tribromophenol increases expression ISO RGD:1354079 6480464 2 more ... CTD PMID:31675489 2-methylcholine affects expression ISO RGD:1354079 6480464 beta-methylcholine affects the expression of LAMA5 mRNA CTD PMID:21179406 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of LAMA5 mRNA CTD PMID:22484513 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1354079 6480464 tetrabromobisphenol A results in increased expression of LAMA5 protein CTD PMID:31675489 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1354079 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LAMA5 mRNA CTD PMID:28628672 3-methylcholanthrene multiple interactions ISO RGD:1551147 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LAMA5 mRNA CTD PMID:23519560 4,4'-sulfonyldiphenol increases expression ISO RGD:1551147 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of LAMA5 mRNA CTD PMID:30951980 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of LAMA5 mRNA CTD PMID:22484513 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of LAMA5 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO RGD:1551147 6480464 Fenretinide results in increased expression of LAMA5 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:1354079 6480464 Decitabine affects the expression of LAMA5 mRNA CTD PMID:23300844 acetamide increases expression EXP 6480464 acetamide results in increased expression of LAMA5 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:1354079 6480464 Acrylamide results in decreased expression of LAMA5 mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of LAMA5 mRNA CTD PMID:22484513 more ... aflatoxin B1 affects methylation ISO RGD:1354079 6480464 Aflatoxin B1 affects the methylation of LAMA5 intron CTD PMID:30157460 aldrin increases expression ISO RGD:1551147 6480464 Aldrin results in increased expression of LAMA5 mRNA CTD PMID:18579281 all-trans-retinoic acid increases expression ISO RGD:1354079 6480464 Tretinoin results in increased expression of LAMA5 mRNA CTD PMID:17138961 all-trans-retinoic acid multiple interactions ISO RGD:1551147 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of LAMA5 mRNA CTD PMID:30951980 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of LAMA5 mRNA CTD PMID:24977338 anthracen-2-amine increases expression EXP 6480464 2-anthramine results in increased expression of LAMA5 mRNA CTD PMID:23038007 aristolochic acid A decreases expression ISO RGD:1354079 6480464 aristolochic acid I results in decreased expression of LAMA5 mRNA, aristolochic acid I results in decreased expression of LAMA5 protein CTD PMID:33212167 arsane increases methylation ISO RGD:1354079 6480464 Arsenic results in increased methylation of LAMA5 gene CTD PMID:24525453 arsenic atom increases methylation ISO RGD:1354079 6480464 Arsenic results in increased methylation of LAMA5 gene CTD PMID:24525453 arsenite(3-) multiple interactions ISO RGD:1354079 6480464 arsenite inhibits the reaction [G3BP1 protein binds to LAMA5 mRNA] CTD PMID:32406909 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of LAMA5 gene CTD PMID:28931070 benzo[a]pyrene decreases expression ISO RGD:1354079 6480464 Benzo(a)pyrene results in decreased expression of LAMA5 mRNA CTD PMID:20106945 , PMID:21632981 benzo[a]pyrene affects methylation ISO RGD:1354079 6480464 Benzo(a)pyrene affects the methylation of LAMA5 exon more ... CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1551147 6480464 Benzo(a)pyrene results in increased methylation of LAMA5 exon, Benzo(a)pyrene results in increased methylation of LAMA5 intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1551147 6480464 Benzo(a)pyrene results in increased expression of LAMA5 mRNA CTD PMID:27195522 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LAMA5 mRNA CTD PMID:18164116 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1354079 6480464 Mustard Gas results in decreased expression of LAMA5 protein CTD PMID:12880345 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LAMA5 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1551147 6480464 bisphenol A results in increased expression of LAMA5 mRNA CTD PMID:32156529 bisphenol A decreases expression ISO RGD:1354079 6480464 bisphenol A results in decreased expression of LAMA5 protein CTD PMID:31675489 bisphenol A multiple interactions ISO RGD:1354079 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of LAMA5 gene CTD PMID:31601247 bisphenol A affects expression ISO RGD:1354079 6480464 bisphenol A affects the expression of LAMA5 mRNA CTD PMID:30903817 bisphenol F multiple interactions ISO RGD:1354079 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of LAMA5 gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LAMA5 mRNA CTD PMID:28628672 , PMID:31601247 bisphenol F multiple interactions ISO RGD:1551147 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of LAMA5 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:1551147 6480464 bisphenol F results in increased expression of LAMA5 mRNA CTD PMID:30951980 boric acid increases expression ISO RGD:1354079 6480464 boric acid results in increased expression of LAMA5 mRNA CTD PMID:27206737 boric acid increases expression ISO RGD:1551147 6480464 boric acid results in increased expression of LAMA5 mRNA CTD PMID:27206737 butanal decreases expression ISO RGD:1354079 6480464 butyraldehyde results in decreased expression of LAMA5 mRNA CTD PMID:26079696 calcitriol increases expression ISO RGD:1354079 6480464 Calcitriol results in increased expression of LAMA5 mRNA CTD PMID:26485663 carbon nanotube increases expression ISO RGD:1354079 6480464 Nanotubes, Carbon results in increased expression of LAMA5 mRNA CTD PMID:24389112 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of LAMA5 mRNA CTD PMID:19395590 chlordecone multiple interactions ISO RGD:1551147 6480464 Chlordecone promotes the reaction [Biomarkers metabolite binds to LAMA5 gene] CTD PMID:31084621 chlordecone decreases expression ISO RGD:1551147 6480464 Chlordecone results in decreased expression of LAMA5 mRNA CTD PMID:33711761 chloropicrin increases expression ISO RGD:1354079 6480464 chloropicrin results in increased expression of LAMA5 mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:1551147 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LAMA5 mRNA CTD PMID:20938992 chrysene increases expression ISO RGD:1551147 6480464 chrysene results in increased expression of LAMA5 mRNA CTD PMID:26377693 cisplatin affects expression ISO RGD:1354079 6480464 Cisplatin affects the expression of LAMA5 mRNA CTD PMID:23300844 cisplatin decreases expression ISO RGD:1354079 6480464 Cisplatin results in decreased expression of LAMA5 mRNA CTD PMID:27392435 cobalt dichloride decreases secretion ISO RGD:1354079 6480464 cobaltous chloride results in decreased secretion of LAMA5 protein CTD PMID:22079246 copper atom multiple interactions ISO RGD:1354079 6480464 [Chelating Agents binds to Copper] which results in decreased expression of LAMA5 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1354079 6480464 [Chelating Agents binds to Copper] which results in decreased expression of LAMA5 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RGD:1551147 6480464 Copper Sulfate results in increased expression of LAMA5 mRNA CTD PMID:18579281 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of LAMA5 mRNA CTD PMID:26577399 cyclophosphamide increases expression ISO RGD:1551147 6480464 Cyclophosphamide results in increased expression of LAMA5 mRNA CTD PMID:30760223 cyclophosphamide multiple interactions ISO RGD:1551147 6480464 5-(N-methyl-N-propargylaminomethyl)-8-hydroxyquinoline inhibits the reaction [Cyclophosphamide results in increased expression of LAMA5 mRNA] CTD PMID:30760223 cyclosporin A decreases expression ISO RGD:1354079 6480464 Cyclosporine results in decreased expression of LAMA5 mRNA CTD PMID:25562108 , PMID:27989131 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of LAMA5 mRNA CTD PMID:23640034 , PMID:23914054 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of LAMA5 mRNA CTD PMID:20032058 dexamethasone multiple interactions ISO RGD:1354079 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LAMA5 mRNA CTD PMID:28628672 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of LAMA5 mRNA] CTD PMID:20032058 dextran sulfate multiple interactions ISO RGD:1551147 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LAMA5 mRNA CTD PMID:29950665 dicrotophos increases expression ISO RGD:1354079 6480464 dicrotophos results in increased expression of LAMA5 mRNA CTD PMID:28302478 diuron decreases expression EXP 6480464 Diuron results in decreased expression of LAMA5 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1354079 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMA5 mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:1354079 6480464 Doxorubicin results in increased expression of LAMA5 mRNA CTD PMID:29803840 ethanol increases expression ISO RGD:1551147 6480464 Ethanol results in increased expression of LAMA5 mRNA CTD PMID:30319688 fenamidone increases expression ISO RGD:1551147 6480464 fenamidone results in increased expression of LAMA5 mRNA CTD PMID:27029645 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of LAMA5 mRNA CTD PMID:30307764 fipronil increases expression EXP 6480464 fipronil results in increased expression of LAMA5 mRNA CTD PMID:31881178 folic acid multiple interactions ISO RGD:1551147 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 fulvestrant multiple interactions ISO RGD:1354079 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of LAMA5 gene, [bisphenol F co-treated with Fulvestrant] results in increased methylation of LAMA5 gene CTD PMID:31601247 fulvestrant increases methylation ISO RGD:1354079 6480464 Fulvestrant results in increased methylation of LAMA5 gene CTD PMID:31601247 gossypol multiple interactions ISO RGD:1354079 6480464 [zoledronic acid co-treated with Gossypol] results in decreased expression of LAMA5 mRNA CTD PMID:19825521 hydrogen peroxide affects expression ISO RGD:1354079 6480464 Hydrogen Peroxide affects the expression of LAMA5 mRNA CTD PMID:21179406 indometacin multiple interactions ISO RGD:1354079 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of LAMA5 mRNA CTD PMID:28628672 L-methionine multiple interactions ISO RGD:1551147 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LAMA5 mRNA CTD PMID:20938992 lead diacetate increases expression ISO RGD:1551147 6480464 lead acetate results in increased expression of LAMA5 mRNA CTD PMID:22609695 menadione affects expression ISO RGD:1354079 6480464 Vitamin K 3 affects the expression of LAMA5 mRNA CTD PMID:20044591 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of LAMA5 mRNA CTD PMID:25972201 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LAMA5 mRNA CTD PMID:18164116 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of LAMA5 mRNA CTD PMID:33484710 paracetamol affects expression ISO RGD:1551147 6480464 Acetaminophen affects the expression of LAMA5 mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of LAMA5 mRNA CTD PMID:32680482 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 perfluorooctanoic acid decreases expression ISO RGD:1354079 6480464 perfluorooctanoic acid results in decreased expression of LAMA5 protein CTD PMID:26879310 phenylmercury acetate increases expression ISO RGD:1354079 6480464 Phenylmercuric Acetate results in increased expression of LAMA5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1354079 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMA5 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1551147 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LAMA5 mRNA CTD PMID:23519560 pirinixic acid multiple interactions ISO RGD:1354079 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LAMA5 mRNA CTD PMID:19710929 potassium dichromate increases expression ISO RGD:1551147 6480464 Potassium Dichromate results in increased expression of LAMA5 mRNA CTD PMID:23608068 resveratrol multiple interactions ISO RGD:1354079 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of LAMA5 mRNA CTD PMID:23557933 retinyl acetate increases expression ISO RGD:1551147 6480464 retinol acetate results in increased expression of LAMA5 mRNA CTD PMID:16772331 SB 431542 multiple interactions ISO RGD:1354079 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LAMA5 mRNA CTD PMID:27188386 sodium arsenite increases expression ISO RGD:1354079 6480464 sodium arsenite results in increased expression of LAMA5 mRNA CTD PMID:29301061 T-2 toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of LAMA5 mRNA CTD PMID:26141394 tamoxifen affects expression ISO RGD:1354079 6480464 Tamoxifen affects the expression of LAMA5 mRNA CTD PMID:14699072 tert-butyl hydroperoxide decreases expression ISO RGD:1354079 6480464 tert-Butylhydroperoxide results in decreased expression of LAMA5 mRNA CTD PMID:15336504 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of LAMA5 mRNA] CTD PMID:20032058 tetrachloromethane affects expression ISO RGD:1551147 6480464 Carbon Tetrachloride affects the expression of LAMA5 mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of LAMA5 mRNA CTD PMID:31150632 thapsigargin decreases expression ISO RGD:1354079 6480464 Thapsigargin results in decreased expression of LAMA5 mRNA CTD PMID:29453283 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of LAMA5 mRNA CTD PMID:23411599 titanium dioxide multiple interactions ISO RGD:1354079 6480464 [Vitallium analog binds to titanium dioxide] which results in increased expression of LAMA5 mRNA CTD PMID:23825117 titanium dioxide multiple interactions ISO RGD:1551147 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of LAMA5 mRNA CTD PMID:29950665 triclosan increases expression ISO RGD:1354079 6480464 Triclosan results in increased expression of LAMA5 mRNA CTD PMID:30510588 tunicamycin decreases expression ISO RGD:1354079 6480464 Tunicamycin results in decreased expression of LAMA5 mRNA CTD PMID:29453283 valproic acid decreases expression ISO RGD:1354079 6480464 Valproic Acid results in decreased expression of LAMA5 mRNA CTD PMID:29154799 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of LAMA5 mRNA CTD PMID:23034163 zalcitabine multiple interactions EXP 6480464 [gp120 protein, Human immunodeficiency virus 1 co-treated with Zalcitabine] results in increased expression of LAMA5 mRNA CTD PMID:18606552 zinc atom increases expression ISO RGD:1354079 6480464 Zinc deficiency results in increased expression of LAMA5 mRNA CTD PMID:22171008 zinc(0) increases expression ISO RGD:1354079 6480464 Zinc deficiency results in increased expression of LAMA5 mRNA CTD PMID:22171008 zoledronic acid multiple interactions ISO RGD:1354079 6480464 [zoledronic acid co-treated with Gossypol] results in decreased expression of LAMA5 mRNA CTD PMID:19825521
